The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

PURPOSE: To evaluate the pan-immune-inflammation value (PIV) and systemic immune-inflammation index (SII) in patients with cutaneous melanoma (CM) under immune checkpoint inhibitor (ICI) therapy. METHODS: PIV and SII were calculated before the start of ICI therapy and at time of progression/death in...

Descripción completa

Detalles Bibliográficos
Autores principales: Susok, L., Said, S., Reinert, D., Mansour, R., Scheel, C. H., Becker, J. C., Gambichler, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508007/
https://www.ncbi.nlm.nih.gov/pubmed/35006344
http://dx.doi.org/10.1007/s00432-021-03878-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508007/
https://www.ncbi.nlm.nih.gov/pubmed/35006344
http://dx.doi.org/10.1007/s00432-021-03878-y

Ejemplares similares